Fresenius Medical Care

113 articles with Fresenius Medical Care

• Fresenius Medical Care completes acquisition of NxStage Medical

  2/26/2019

  Fresenius Medical Care, the world's largest provider of dialysis products and services, has successfully completed the acquisition of NxStage Medical, Inc., following approval by antitrust authorities in the United States.

• Fresenius Medical Care North America Launches 2008T BlueStar™ Hemodialysis Machine Across the U.S.

  2/11/2019

  Fresenius Medical Care North America Advances Renal Care with Next Generation Dialysis Delivery System Featuring More Than 30 Enhancements

• Fresenius Kidney Care Leads Industry in Patient Safety Program for Third Straight Year

  1/31/2019

  Nearly 100 Percent of Fresenius Kidney Care Facilities Achieve 5-Diamond Patient Safety Status in 2018

• Velphoro® Doubles Percentage of Patients Reaching Target Serum Phosphorous Levels in New Study Published in Journal of Renal Nutrition

  1/28/2019

  Fresenius Medical Care North America Examines Impact of Sucroferric Oxydroxide on Hemodialysis Patients with Kidney Failure; High Serum Phosphorous Levels Previously Linked to Increased Cardiovascular Disease

• 1 in 6 Outpatient Dialysis Patients with Acute Kidney Injury Lasting More Than 90 Days Still Recover Kidney Function, According to New Data from Fresenius Medical Care North America

  1/24/2019

  New Insight from 9,000 AKI Patients Receiving Outpatient Dialysis Treatment; Large Collection of AKI Data is International First and Aims to Spur Further Investigation   [24-January-2019]   WALTHAM, Mass. , Jan. 24, 2019 /PRNewswire/ --  Fresenius Medical Care North America (FMCNA), the nation's leading renal care company, announces preliminary results from an analysis o

• CytoSorbents Announces Expansion of CytoSorb® Partnership with Fresenius Medical Care

  1/22/2019

  Agreement brings innovative CytoSorb® therapy to Korea and Mexico and sets the stage for future growth   [22-January-2019]   MONMOUTH JUNCTION, N.J. , Jan. 22, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its  CytoSorb®  blood purification technology to treat deadly inflammation in critically-ill and ca

• Lower Hospitalization Rates Observed Among Patients New to Hemodialysis with Relative Blood Volume Monitoring Utilizing Crit-Line®

  10/26/2018

  Researchers Discuss Benefits of Fluid Management for Dialysis Patients at the American Society of Nephrology's 2018 Kidney Week Symposium.

• 

  Pfizer, Novartis to Close North Carolina Sites Ahead of Hurricane Florence

  9/13/2018

  Although Hurricane Florence has been downgraded to a Category 2, the massive storm has the potential to dump enough rain to produce catastrophic flooding across the Carolinas. Despite the downgrade, Pfizer is taking no chances and will close its North Carolina injectables plant ahead of the storm.
• 

  A Look at the Top 10 Medical Device Companies in 2018

  6/12/2018

  The medical device market was about $521.2 billion last year and is projected to hit $674.5 billion by 2022. Here’s a look at the top 10 medical device companies in the world this year.

• Fresenius Medical Care and Humacyte announce strategic global partnership supported by a $150M equity investment

  6/11/2018

  Fresenius Medical Care and Humacyte, Inc. announced a strategic, global partnership and a $150M USD equity investment.

• RenalSense Announces Distribution Agreement With Fresenius Medical Care

  4/30/2018

    [30-April-2018]   JERUSALEM, April 30, 2018 /PRNewswire/ -- RenalSense(R) has entered into an agreement with Fresenius Medical Care (Bad Homburg) for distribution of its Clarity RMS(R) critical care urine monitoring system in Europe, the Middle East, and Africa (EMEA). Fresenius Medical Care will market the company's products in 85 EMEA countries through its acute care div

• Fresenius Medical Care North America, American Nephrology Nurses Association Announce Recipients of Nursing Educational Scholarships

  4/18/2018

  Fresenius Medical Care North America (FMCNA) and the American Nephrology Nurses Association (ANNA) announced five recipients of educational scholarships at ANNA's 2018 National Symposium in Las Vegas.

• Modern Healthcare Honors Fresenius Medical Care North America's Saurabh Tripathi with Minority Executives to Watch in Healthcare Award

  3/14/2018

  The profiles of all the winners were featured in the February 26, 2018 print issue of Modern Healthcare

• Fresenius Medical Care North America and National Kidney Foundation Announce National Partnership

  2/28/2018

  As National Presenting Sponsor of the 2018 Kidney Walks, FMCNA Pledges $750,000 toward Kidney Disease Research and Support

• Fresenius Medical Care Achieves A Milestone in Expanding Its Asian Operations

  12/1/2017

  Fresenius Medical Care launched last week in Quanzhou its first independent dialysis center in China.

• Fresenius Medical Care North America Sets Record in Surpassing its Kidney Walk Fundraising Goal

  11/29/2017

  FMCNA raises largest amount ever by a National Team during the 2017 Kidney Walks for the National Kidney Foundation.

• Fresenius Medical Care Achieves Improved Health Outcomes and Savings Through National Medicare Demonstration Program

  11/27/2017

  This success was validated by an independent report from Lewin Group, which showed a nearly nine percent decrease in hospitalization rates for these patients during the same time.

• Fresenius Medical Care Showcases Global Research Leadership at World’s Largest Gathering of Kidney Professionals

  11/3/2017

  Fresenius Medical Care announced that company researchers and clinical experts from across the globe will present 77 research abstracts at the 2017 American Society of Nephrology’s (ASN) Kidney Week Symposium.

• Fresenius Medical Care Divests Shiel Medical Laboratory to Quest Diagnostics for Undisclosed Sum

  9/28/2017

• Fresenius Medical Care Unveils Malaysia's First Peritoneal Dialysis Products Manufacturing Plant

  9/14/2017